When comparing victims of fraud to those who had never been victimized, lead authors Dr. Kang Lee and doctoral researcher Rebecca Judges at the Ontario Institute for Studies in Education (OISE) at the University of Toronto, ...
Apr 17, 2017
0
1
A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.
Jan 9, 2017
0
1
Do you take time to read the risk warnings on drug websites before you take the drug?
Oct 12, 2016
0
0
New York state has launched an antitrust probe into Mylan's sale of the EpiPen anti-allergy injector to local school systems, New York's attorney general announced Tuesday.
Sep 6, 2016
0
3
The maker of EpiPens will start selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues—and looming competition threatens its near-monopoly.
Aug 29, 2016
0
0
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.5 billion purchase of the generic drug business of competitor Allergan next week after federal regulators ...
Jul 27, 2016
0
5
It was definitely déjà vu in the media today. Reuters, The New Yorker, Los Angeles Times, and more were back on the "brain training prevents dementia" bandwagon.
Jul 26, 2016
0
14
An appeal to emotions like excitement or anger is a key persuasion tactic used by fraudsters to mislead the elderly.
May 4, 2016
0
5
A new survey finds that homeopathic medicines are primarily used by a small segment of the U.S. population for common, self-limited conditions such as the common cold or back pain. The report published in the American Journal ...
Feb 18, 2016
0
11
Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.
Sep 18, 2015
0
6
